Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study will evaluate the safety and efficacy of Tesomet (tesofensine + metoprolol) in subjects with PWS.
Epistemonikos ID: 957dad9e48566ffac3b73761fa522d176aa5a933
First added on: May 10, 2024